This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chavez-Reyes, A. Articles by Lozano, G. Search for Related Content PubMed PubMed Citation Articles by Chavez-Reyes, A. Articles by Lozano, G.

Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets

¹ Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
² Department of Microbiology and Immunology, School of Biological Sciences, Universidad Autónoma de Nuevo León, Monterrey, Mexico; and
³ Departments of Pathology and Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts

The p53 tumor suppressor ensures maintenance of genome integrity by initiating either apoptosis or cell cycle arrest in response to DNA damage. Deletion of either mdm2 or mdm4 genes, which encode p53 inhibitors, results in embryonic lethality. The lethal phenotypes are rescued in the absence of p53, which indicates that increased activity of p53 is the cause of lethality in the mdm2- and mdm4-null embryos. Here we show that mdm2-null embryos die because of apoptosis initiated at 3.5 days postcoitum (dpc). Partial rescue of mdm2-null embryos by deletion of bax allows survival to 6.5 dpc and alters the mechanism of death from apoptosis to cell cycle arrest, indicating that bax is a critical component of the p53 pathway in early embryogenesis. The death of mdm4-null embryos is due to p53-initiated cell cycle arrest at 7.5 dpc. Deletion of p21(p21^waf1/cip1), a p53 downstream target partially responsible for cell cycle arrest, does not rescue this phenotype; however, deletion of p21 alters the mechanism of cell death from lack of proliferation to apoptosis. Thus, in both examples, deletion of a p53 downstream target gene allows p53 to redirect its efforts, highlighting a high degree of plasticity in p53 function.

This article has been cited by other articles:

				J. A. Barboza, T. Iwakuma, T. Terzian, A. K. El-Naggar, and G. Lozano Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities Mol. Cancer Res., June 1, 2008; 6(6): 947 - 954. [Abstract] [Full Text] [PDF]

				T. Terzian, Y.-A. Suh, T. Iwakuma, S. M. Post, M. Neumann, G. A. Lang, C. S. Van Pelt, and G. Lozano The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss Genes & Dev., May 15, 2008; 22(10): 1337 - 1344. [Abstract] [Full Text] [PDF]

				M. Maetens, G. Doumont, S. D. Clercq, S. Francoz, P. Froment, E. Bellefroid, U. Klingmuller, G. Lozano, and J.-C. Marine Distinct roles of Mdm2 and Mdm4 in red cell production Blood, March 15, 2007; 109(6): 2630 - 2633. [Abstract] [Full Text] [PDF]

				H. Fan, J. Stefkova, and S. S. El-Dahr Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682. [Abstract] [Full Text] [PDF]

				S. Xiong, C. S. Van Pelt, A. C. Elizondo-Fraire, G. Liu, and G. Lozano Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development PNAS, February 28, 2006; 103(9): 3226 - 3231. [Abstract] [Full Text] [PDF]

				J. D. Grier, S. Xiong, A. C. Elizondo-Fraire, J. M. Parant, and G. Lozano Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4 Mol. Cell. Biol., January 1, 2006; 26(1): 192 - 198. [Abstract] [Full Text] [PDF]